BioCryst Pharmaceuticals Inc.

NASDAQ: BCRX
Share price (2/14/25): $9.05
Market cap (2/14/25): $1.875 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Automatic shelf registration

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Gayer Charles K

Thackray Helen M.

Stonehouse Jon P

News Filter

Material Disclosure

Announces Preliminary Full Year 2024 ORLADEYO® (Berotralstat) Net Revenue of $437 Million

Material Disclosure

Reports Third Quarter 2024 Financial Results and Provides Business Update

Begins Enrollment in Phase 1 Trial Evaluating BCX17725, a KLK5 Inhibitor, for the Treatment of Netherton Syndrome

Proxies Filter

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC